Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alexion's Soliris To Treat EU Patients With NMOSD

Europe — • Source: Shutterstock

Related Content

Rivals Await CHMP Decisions On Drugs For NMOSD

Jul 23 2019

CHMP Fast-Tracks BMS' Empliciti Nod

Jan 29 2016

Viela Adds Momentum To Burgeoning NMOSD Market With Pivotal Inebilizumab Results

Jan 03 2019

Related Companies

Alexion Pharmaceuticals Inc.

Viela Bio, Inc.

Roche Holding AG

Chugai Pharmaceutical Co., Ltd.

Bristol Myers Squibb Company

AbbVie Inc.

Additional Topics

Europe Approvals Commercial Rare Diseases Neurology Cancer BioPharmaceutical

More from Neurological

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window